On July 26-27, 2024, Suzhou Chung-Hwa Chemical & Pharmaceutical Industrial Co., Ltd. (hereinafter referred to as "Suzhou Chung-Hwa Chemical & Pharmaceutical")'s product calcium polycarbophil was unveiled at the "8th Annual Academic Conference of the Chinese Digestive Psychosomatic Alliance" co-organized by the Beijing Health Promotion Association and the Chinese Digestive Psychosomatic Alliance. The academic conference was grandly held in Shanghai.

This conference covers hot topics, difficulties and common problems related to clinical digestive psychosomatic diseases, and discusses the progress of clinical and basic research on digestive system diseases.

Libofei ^® calcium polycarbophil, as the star product of Suzhou Chung-Hwa Chemical & Pharmaceutical, provides a new treatment plan for constipation for clinicians. At this conference, Suzhou Chung-Hwa shared with the participants the basic information and mechanism of action of Libofei ^® calcium polycarbophil. Calcium polycarbophil is a high molecular polymer that forms a hydrophilic gel by absorbing water and swelling, which participates in the formation of stool, increases the water content and volume of stool, makes the stool fluffy and soft and easy to discharge, and provides a highly safe constipation treatment option for clinicians.

At this conference, Libofei ^® (calcium polycarbophil tablets and calcium polycarbophil granules), a brand under Suzhou Chung-Hwa Chemical & Pharmaceutical, exchanged ideas and shared research results with participants, actively promoting the improvement and development of clinical diagnosis and treatment technologies for digestive diseases. At the same time, Suzhou Chung-Hwa Chemical & Pharmaceutical will continue to contribute to the development of China's digestive disease field.